
==== Front
Arch Virol
Arch. Virol
Archives of Virology
0304-8608 1432-8798 Springer-Verlag Vienna 

3994516
BF01378969
10.1007/BF01378969
Original Papers
Pathogenetic observations on pleural effusion disease in rabbits
Fennestad K. L.  grid.6203.70000000404174147Animal Department, Statens Seruminstitut, Copenhagen, Denmark 
1985 
84 3 163 174
2 6 1984 18 9 1984 © Springer-Verlag 1985This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.Summary
A pathogenetic study of pleural effusion disease (PED) in rabbits was made, using the virulent PED agent or virus (PEDV) and an avirulent derivate of this isolate. Independent of infective dose within the range examined, the virulent isolate caused fatal clinical disease, whereas the avirulent isolate caused subclinical infection. The two isolates differed in rapidity of initial spread of infection and in the maximum virus titres in serum, but they both resulted in a similar low level persisting viraemia. Circulating virulent virus gradually became avirulent during the viraemia.

Avirulent infection induced protective immunity to virulent challenge during the first week after primary infection, but full clinical protection was not established until after the fourth week.

The findings, corrobated with other closely comparable observations, suggest that the emergence of PED as an intercurrent mortality problem during rabbit passage of pathogenicTreponema pallidum is the result of a specific selective pressure on a benign passenger virus. The expression of virulence of PEDV appears to be dependent on length of interval between passages.

Keywords
Virus TitreVirulent IsolatePrimary InfectionProtective ImmunityVirulent Challengeissue-copyright-statement© Springer-Verlag 1985
==== Body
With 4 Figures
==== Refs
References
1. Fennestad K. L.  Skovgaard Jensen H.-J.  Møller S.  Weis Bentzon M.   Pleural effusion disease in rabbits. Clinical andpost mortem  observations Acta path. microbiol. scand. 1975 B 83 541 548 
2. Fennestad K. L.  Haahr S.  Bruun L.   Pleural effusion disease in rabbits. Interferon in body fluids and tissues after experimental infection Acta path. microbiol. scand. 1979 B 87 311 315 
3. Fennestad K. L.  Bruun L.  Wedø E.   Pleural effusion disease agent as passenger ofTreponema pallidum  suspensions from rabbits. Survey of laboratories Brit. J. Vener. Dis. 1980 56 198 203 7000304 
4. Fennestad K. L.  Mansa B.  Larsen S.   Pleural effusion disease in rabbits. Observations on viraemia, immunity and transmissibility Arch. Virol. 1981 70 11 19 7332487 
5. Fennestad K. L.  Bruun L.  Haahr S.   Interferon in rabbit sera after inoculation withTreponema pallidum  suspensions contaminated with PED virus Br. J. Vener. Dis. 1982 58 143 146 6177375 
6. Fennestad K. L.  MacNaughton M. R.   Pleural effusion disease in rabbits. Properties of the aetiological agent Arch. Virol. 1983 76 179 188 6409056 
7. Gudjónsson H.  Skog E.   Fever after inoculation of rabbits withTreponema pallidum  Brit. J. Vener. Dis. 1970 46 318 322 4919016 
8. Gudjónsson H.  Newman B.  Turner T. B.   Screening out a virus-like agent from the testicular suspension of the Nichols pathogenicT. pallidum . With observations on certain characteristics of the agent Brit. J. Vener. Dis. 1972 48 102 107 4624383 
9. Jørgensen B. B.   Spontaneous deaths among rabbits inoculated withTreponema pallidum  less than 2 weeks before Z. Versuchstierk. 1968 10 46 54 
10. Menke H. E.  van der Heijden C. A.  Kruizinga W.  Kruijt B. C.  Osterhaus A. D. M. E.   Intercurrent death of rabbits after inoculation withTreponema pallidum  in the Netherlands 1980 Stuttgart Gustav Fischer 263 268 
11. Mims C. A.   General features of persistent virus infections Postgr. Med. J. 1978 54 581 586 
12. Nelson R. A.  Mayer M. M.   Immobilization ofTreponema pallidum in vitro  by antibody produced in syphilitic infection J. Exp. Med. 1949 89 369 393 18113911 
13. Osterhaus A. D. M. E.  Teppema J. S.  van Steenis G.   Coronavirus-like particles in laboratory rabbits with different syndromes in The Netherlands Lab. Anim. Sci. 1982 32 663 665 6761509 
14. Riley V.   Biological contaminants and scientific misinterpretations Cancer Res. 1974 34 1752 1754 4833921 
15. Rowson K. E. K.  Mahy B. W. J.   Lactic dehydrogenase virus 1975 Wien-New York Springer 
16. Small J. D.  Aurelian L.  Squire R. A.  Strandberg J. D.  Melby E. C.  Turner Th. B.  Newman B.   Rabbit cardiomyopathy associated with a virus antigenically related to human Coronavirus Strain 229E Am. J. Pathol. 1979 95 709 728 222151 
17. Stroop W. G.  Baringer J. R.   Persistent, slow and latent viral infections Prog. med. Virol. 1982 28 1 43 6283598 
18. Vaisman A.  Paris-Hamelin A.  Catalan F.  Dunoyer F.   Entretien au Laboratoire des souches de tréponèmes pathogènes. Precautions à prendre Proph. sanit. morale 1973 45 71 73

